• linkedin
  • Increase Font
  • Sharebar

    Vitrectomy offers a viable therapeutic option for DME

    In an era when pharmacological therapy has become the mainstay for treatment of diabetic macular edema (DME), pars plana vitrectomy (PPV) deserves consideration as a reasonable alternative for early DME in appropriate patients, according to Maurice B. Landers III, MD.

    Dr. Landers

    “Anti-VEGF therapy has become the current standard of care for treatment of DME in the United States,” said Dr. Landers, professor of ophthalmology, University of North Carolina Medical School, Chapel Hill. “But it is extremely expensive and outcomes with its use in the real world are nowhere near as good as the results obtained in clinical trials.”

    Dr. Landers pointed out that modern PPV is safe, effective for reducing DME, less expensive, and the only affordable option for treating DME in most countries of the world.”



    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow

    var script= ' ';